ClinicalTrials.Veeva

Menu

Compare Outcome of Enhanced Recovery After Cesarean Surgery and Conventional Care

R

Rajavithi Hospital

Status

Completed

Conditions

To Determine Whether ERAS Can Reduce Length of Stay in Pregnant Women After Cesarean Section

Treatments

Procedure: ERAS

Study type

Interventional

Funder types

Other

Identifiers

NCT04530851
103/2562

Details and patient eligibility

About

Research objective to compare outcome(Length of stay, pain score, opioid drug use, Bowel function and complication ) of ERAS protocol and conventional care in pregnant women after elective cesarean section in Rajavithi hospital.

Full description

Research design is Randomized control trial. The pregnant women who go to elective cesarean section don't know the allocation. The group of ERAS protocol was separated from Conventional care in patient care unit.

The Pregnant are randomly in two group. In the ERAS group the pregnant receive the the intervention for preoperative care(Counselin, H2- antagonist and metroclopramide for prevent aspiration, Drink clear liquid until 2 hour before surgery), Intraoperative care (first generation cephalosporin in 60 minute before surgery, Clorhexidine for skin cleansing and Povidine for vaginal cleansing, regional anesthesia, keep warming, blunt expansion of uterine incision, do not peritoneal suture and subcuticular suture if less than 2 cm, local wound anesthesia.), post operative care ( Paracetamol and NSAIDs for for pain control, early remove catheter and ambulation, 5-HT3 antagonist for prevent nausea)

Enrollment

80 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant women who scheduled for elective Cesarean section at Rajavithi Hospital

Exclusion criteria

  • Pregnant women who has preeclampsia with severe feature
  • Pregnant women who has diabetes mellitus with uncontrolled blood sugar
  • Pregnant women who has blood loss > 1,500 ml after surgery
  • Pregnant women who has chrioamnionitis.
  • Pregnant women who has severe medical disease
  • Pregnant women who has BMI >= 40 kg/m2
  • Pregnant women who has placenta adherence.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Conventional care
No Intervention group
Description:
This group is conventional care of pregnant women after Cesarean section
ERAS protocol
Experimental group
Description:
This protocol for improve outcome of pregnant women after Cesarean section
Treatment:
Procedure: ERAS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems